ADVERTISEMENTs
Emory University recognizes Suresh Ramalingam for scientific research
The Levy Award program includes a trophy and a $2,000 research fund contribution
-
Malvika Choudhary - Mon, 28, Apr 2025
- 15:06 EDT
- 58
Suresh Ramalingam / Emory University
Emory University awarded Suresh S. Ramalingam with the 2025 Albert E. Levy Award for Excellence in Scientific Research.
The Levy Award, administered by the University Research Committee (URC), annually recognizes one junior and one senior faculty member at Emory for outstanding contributions to scientific research.
Also Read: Rajiv Vinnakota to receive Rutgers University honorary degree
Executive director of Winship Cancer Institute and professor of hematology and medical oncology, Ramalingam holds the Roberto C. Goizueta Distinguished Chair for cancer research at Emory University School of Medicine and is nationally recognized for his pioneering work in lung cancer research.
His leadership in developing third-generation epidermal growth factor receptor (EGFR) inhibitors, including Osimertinib, has significantly advanced treatment options for patients with early-stage and advanced lung cancer.
Landmark clinical trials led by Ramalingam, including FLAURA (First-Line Osimertinib vs. Standard EGFR-TKI Therapy in Patients With EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer) and LAURA (Locally Advanced Unresectable EGFR-Mutated Non-Small-Cell Lung Cancer Treated With Osimertinib Following Chemoradiotherapy), demonstrated substantial improvements in patient outcomes.
The LAURA trial, in particular, showed a median progression-free survival of 39.1 months compared to 5.6 months with placebo for patients with unresectable stage III EGFR-mutated non-small cell lung cancer, setting a new standard of care and earning multiple FDA approvals.
Ramalingam’s career is distinguished by numerous honors, including the Distinguished Cancer Scholar Award, the Clinical Investigator Team Leadership Award from the National Cancer Institute, and the Paul Bunn Award for Scientific Merit.
He has led major NIH-funded initiatives such as Emory’s first Lung Cancer Specialized Program of Research Excellence (SPORE) and has held more than 50 national leadership roles, including serving as chair of the Thoracic Malignancies Committee at ECOG-ACRIN and editor-in-chief of cancer.
Board certified in medical oncology, Ramalingam completed his fellowship in hematology and oncology at the University of Pittsburgh Medical Center and his residency and internship in internal medicine at Wayne State University. He earned his MBBS degree from Kilpauk Medical College in Chennai, India.
The Levy Award program was established by Edith Levy Elsas in memory of her father, Albert E. Levy, and includes a trophy and a $2,000 research fund contribution. Initially overseen by Emory’s Sigma Xi chapter, it was reinstated in 2000 and continues to highlight Emory faculty members’ outstanding scientific achievements across disciplines.
Related
.jpeg)
.JPG)
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
E Paper
ADVERTISEMENT
.jpg)
Video
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login